Next Level Wound Care
Created to Improve Lives
Every year, 5 million people in Germany suffer from extensive, chronic wounds such as diabetic foot syndrome, bedsores, leg ulcerations, as well as fungal infections and superinfections like those caused by severe burns. Patients‘ quality of life is heavily impacted as the healing process of these wounds is time-consuming, painful and expensive.
Driven by our passion to provide a new quality of life for those affected, we have invented and patented an innovative and effective treatment approach for wounds. Our specialists developed the Plasma- or CPTpatch, an active wound dressing that effectively treats wounds.
As the first company worldwide that uses the patented Active Glow technology, we enable a groundbreaking application that even combats multidrug resistance germs – without pain, covering large areas, quick and secure.
Wound infections – especially those caused by multi-resistant germs – are one of the most common complications for general wound healing, acute (burn) wounds as well as surgeries.
At a Glance
Leading technology
Based on over 6 years of application-oriented research and development, we created a new way of treating wounds. The essence of our worldwide unique and patented Active Glow technology is cold plasma. Numerous studies have confirmed the positive effect of cold plasma on healing wounds and killing even multi-resistant germs.
Fast and without pain
The treatment with our active wound dressing takes only 2 minutes and is absolutely painfree. Initial results can often be seen after just a few days of treatment. The effects of cold plasma enables a lasting care for the damaged tissue.
Clinically proven
The outstanding effect and the safety of cold plasma have been confirmed in numerous studies and scientific publications.
Easy to use
The CPTpatch was designed to meet the needs of patients and users. As a convenient and non-invasive treatment, it can be delegated and is even suitable for home care use in future.
Added value to healthcare
By using our technology, the costs of thousands of wound dressings, treatments and complication rates due to infections with multi-resistant bacteria can be dramatically reduced. This significantly eases the burden upon the healthcare system while increasing patient well-being.
Reimbursement
Compared to traditional and other modern wound therapies, wounds can be better treated using our CPTpatches. Even infections caused by multi-resistant pathogens are treated locally. The health care system (both outpatient and clinical) thus realizes enormous savings and therefore health insurance companies can cover the cost of treatment.
.
Product
The CPTpatch is a disposable, sterile, active wound dressing. CPTpatches are exclusively used in combination with the energy supply unit CPTcube. The CPTpatch has an atraumatic, self-adhesive border for an easy attachment to the area of application. During treatment, a physical plasma in the form of a purple glowing discharge is generated between the wound and the patient side of the CPTpatch.
The plasma converts the air within the defined volume between the CPTpatch and the wound surface into a physicallly active state. This is associated with the generation of alternating electric fields, light in the UV and infrared range, the formation of ions, and a slight increase in temperature. These components have an impact both on the whole skin-surface covered and in small pores, as well as skin depressions. The combination of these physical mechanisms results in an antimicrobial/antifungal effect of the physical plasma and stimulation of wound healing.
Any Questions?
Click here to find all the relevant information.
About us
COLDPLASMATECH emerged as a spin-off out of the Leibniz Institute for Plasma Science and Technology e.V. in Greifswald, Germany.
The interdisciplinary team surrounding Tobias Güra and Dr. Carsten Mahrenholz combines scientific skills and technical know-how at the highest level.
Contact us!
Top10, Eminent Leaders in Healthcare 2020
#1 Health&Science, Top100 Watchlist 2019
Fellow of the Lindau Nobel Laureate Meetings
Greifswald Business Award, University Club
Leibniz Gründerpreis, Leibniz Gemeinschaft
Abgeordneter, YL Gesundheitsparlament
News
- All
- Informationen
- Medien
- Preise
- Uncategorized
Finanzierungsrunde erfolgreich geschlossen
Jetzt wissen wir, wonach Plasma riecht und die Antwort gibt vielen Menschen Hoffnung
MDR Fernsehbeitrag – Eine Erfindung zur besseren Wundheilung
Neue Plasmatherapie hilft bei Wundheilung
Erste Zentren mit CPTcubes augestattet
Corona Pandemie – wir bleiben operativ.
Plasma-Pflaster hilft Wunden heilen
Zertifikat für Medizinprodukt wurde erteilt
Interview – TOP10 Eminent Leaders in Healthcare 2020
Watchlist 2019: Zehn Menschen, die den Health & Science-Bereich verändern
Coldplasmatech Offers Greatest Public Value
Deutscher Innovationspreis 2018 für Coldplasmatech
What is new on Facebook
COLDPLASMATECH
COLDPLASMATECH entwickelt die erste aktive Wundauflage (Plasma-Patch) zur Behandlung chronischer Wunden mittels kaltem, physikalischem Plasma.
Kaltplasma: Chronische Wunden bei Diabetischem Fuß behandeln
focus-arztsuche.de
Kaltplasma schließt Wunden – selbst solche, bei denen herkömmliche Therapien seit Jahren versagen. Das macht vor allem Diabetespatienten Hoffnung.
Was macht mich zum guten Wundbehandelnden? | IWC 2021
www.wundcongress.de
Prof. Dr. Volker Großkopf interviewt Anita Mysor zu ihrem Vortrag "Was macht mich zum guten Wundbehandelnden? " auf dem IWC 2021Network
Supporters
Media
Network
